Useful endoscopic ultrasonography to assess the efficacy of neoadjuvant therapy for advanced esophageal carcinoma: Based on the response evaluation criteria in solid tumors

Digestive Endoscopy

Volumn 17, Issue 1, 2005, Pages 59-63

  Ota, Masaho ^a,b   Murata, Yoko ^a   Ide, Hiroko ^a   Eguchi, Reiki ^a   Nakumura, Tsutomu ^a   Hayashi, Kazuhiko ^a   Narumiya, Kousuke ^a   Oi, Itaru ^a   Takasaki, Ken ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Endoscopic ultrasonography (EUS); Esophageal carcinoma; Neoadjuvant therapy; Response Evaluation Criteria in Solid Tumors (RECIST)

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; SOLID TUMOR;

EID: 14644432473     PISSN: 09155635     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1443-1661.2005.00458.x     Document Type: Article

References (16)

1. Ota M, Murata Y, Ide H et al. An evaluation of the efficacy of preoperative therapy for thoracic esophageal carcinoma using endoscopic ultrasonography. Dig. Endosc. 1998; 10: 122-8.
2. Therasse P, Arbuck SG, Eisenhauer EA et al. New guideline to evaluate the response to treatment in solid tumors. J. Natl Cancer Inst. 2000; 92: 205-16.
3. Japanese Society for Esophageal Disease. Guidelines for Clinical and Pathologic Studies on Carcinoma of the Esophagus, 9th edn. Kanehara, Tokyo. 2001.
4. WHO. WHO Handbook for Reporting Results of Cancer Treatment, Offset Publication no. 48. World Health Organization, Geneva. 1979.
5. Miller AB, Hogestraeten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
6. Isenberg G, Chak A, Canto MI et al. Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation. Gastrointest. Endosc. 1998; 48: 158-63.
7. Willis J, Cooper GS, Isenberg G et al. Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma. Gastrointest. Endosc. 2002; 55: 655-61.
8. Hirata N, Kawamoto K, Ueyama T, Masuda K, Utsunomiya T, Kuwano H. Using endosonography to assess the effects of neoadjuvant therapy in patients with advanced esophageal cancer. Am. J. Roentgenol. 1997; 169: 485-91.
9. Chak A, Canto MI, Cooper GS et al. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients. Cancer 2000; 88: 1788-95.
10. Kusaba H, Saijo N. A summary report of response evaluation criteria in solid tumors (RECIST criteria). Jpn J. Cancer Chemother. 2000; 27: 1-5.
11. Sasaki T. New guideline to evaluate the response to treatment 'RECIST'. Jpn J. Cancer Chemother. 2000; 27: 2179-84.
12. Laterza E, de Manzoni G, Guglielmi A, Rodella L, Tedesco P, Cordiano C. Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann. Thorac. Surg. 1999; 67: 1466-9.
13. Mallery S, DeCamp M, Bueno R. Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma. Cancer 1999; 86: 764-9.
14. Beseth BD, Bedford R, Isacoff WH, Holmes EC, Cameron RB. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am. Surg. 2000; 66: 827-31.
15. Souquet JC. Endosonography in the clinical TNM staging and follow-up after combined radiotherapy of inoperable esophageal carcinoma. Gastrointest. Endosc. 1991; 37: 243.
16. Hordijk ML, Kok TC, Wilson JHP. Assessment of response of esophageal carcinoma to induction chemotherapy. Endoscopy 1993; 25: 592-6.